News

Kronos Bio Appoints Barbara Kosacz, Chief Operating Officer and General Counsel

July 20, 2020

Kronos Bio and Gilead Sciences Enter Into Asset Purchase Agreement for Gilead’s SYK Inhibitor Portfolio

July 16, 2020

Kronos Bio Reports Positive Results of Preclinical Study of KB-0742, an Investigational CDK9 Inhibitor, Demonstrating Potency, Selectivity and Anti-tumor Activity in Prostate Cancer Model

July 9, 2020

Kronos Bio Appoints Industry Veteran, Jennifer Nicholson, M.H.A., as Vice President, Regulatory Affairs

July 7, 2020

Kronos Bio Expands Leadership Team with Appointment of Seasoned Drug Discovery Leader Christopher Dinsmore, Ph.D., as Chief Scientific Officer

June 16, 2020

Kronos Bio Announces Participation in the Jefferies Virtual Healthcare Conference

May 26, 2020

Events

03/06/2020

4:30 pm

EDT

Jefferies 2020 Healthcare Conference Webinar

Click to visit: Kronos Bio Jefferies 2020 Healthcare Conference Webinar

Contact

Headquarters

Kronos Bio, Inc.
1300 So. El Camino Real
Suite 300
San Mateo, CA 94402

Research Facility

SmartLabs
21 Erie Street
Suite H
Cambridge, MA 02139

PARTNERING INQUIRIES

bd@kronosbio.com

MEDIA INQUIRIES

media@kronosbio.com

EMPLOYMENT INQUIRIES

careers@kronosbio.com

© 2020 All rights reserved